Health & Biotech Equities Category Report
Last modified: December 1, 2009
The Health & Biotech ETFdb Category contains 22 ETFs with a total market capitalization of approximately $9.65 billion (as of December 1, 2009)
The following are the three largest ETFs in this ETFdb Category by market capitalization (as of December 1, 2009):
| Ticker | ETF | Market Cap |
|---|---|---|
| XLV | State Street Health Care Select SPDR | $2.34 billion |
| PPH | Merrill Lynch Pharmaceutical HOLDRS | $1.65 billion |
| IBB | iShares Nasdaq Biotechnology Fund | $1.45 billion |
View all ETFs in this ETFdb Category
The Health & Biotech ETFdb Category includes funds holding stocks of companies engaged in pharmaceuticals, health care, and biotechnology industries. ETFs in this ETFdb Category include broad-based funds holding various types of health care companies, as well as more focused funds targeting specific corners of the market, including:
Pro Membership Required to Continue Reading 
To continue reading this article, you must be an ETFdb Pro member. Please login or begin your 7-day free trial to continue reading. There are several benefits to becoming an ETFdb Pro member today:
Get valuable insight from our analysts in the ETFdb Category reports, with in-depth breakdown every ETF niche, large or small.- Get portfolio guidance on nearly every possible investor scenario and include detailed information on risk profiles, asset correlation, portfolio management, and more.
- Get access to our premium monthly newsletter ETF Edge.
- Participate in Monthly Q&A's with our Senior Analyst Michael Johnston.
Begin Your Free 7-Day Trial Now – or – Read more about ETFdb Pro
